Skip to content

NUTRA PHARMA CORP.

NPHC

CIK 0001119643

← back to feed
Revenue (TTM)
$255.99K
+4.6% YoY Q1 May 2026
Net Income (TTM)
−$2.02M
−59.2% YoY Q1 May 2026
EPS Diluted (TTM)
$0.00
Q1 May 2026
Gross Margin
85.3%
Q1 May 2026
Operating Margin
-537.4%
Q1 May 2026
Net Margin
-788.5%
Q1 May 2026
Free Cash Flow (TTM)
−$1.09M
Q1 May 2026
Cash
$12.18K
Q1 May 2026
Total Debt
$8.63M
Q1 May 2026
Shares Outstanding
7.16B sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings